How Has The Tissue Engineering Market Size Evolved In Recent Years?
The tissue engineering market has seen considerable growth due to a variety of factors.
• The market size for tissue engineering has witnessed a swift expansion in recent times. The market is projected to escalate from $15.21 billion in 2024 to $17.48 billion in 2025, with a compound annual growth rate (CAGR) of 14.9%. The growth during the historic period can be credited to developments in biomaterials, an increase in the elderly population, a higher prevalence of chronic diseases, regulatory backing for regenerative medicine, and a surge in patient demand for organ transplants.
What is the Forecasted Market Size and CAGR for the Tissue Engineering Market?
The Tissue Engineering market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of tissue engineering is projected to witness considerable growth progressively in the coming years. It is anticipated to reach $29.92 billion in 2029 with a compound annual growth rate (CAGR) of 14.4%.
This surge during the future projection period can be linked to precision medicine strategies, heightened emphasis on immunomodulation, growing utilization in orthopedics, increased financing and investment, and a rising incidence of chronic diseases. In the future projection period, significant trends will comprise the incorporation of nanotechnology, 3D cell culture methods, the advancement of organ-on-a-chip technology, the inclusion of artificial intelligence, and innovative cell sources.
What Key Factors and Trends Are Driving The Growth Tissue Engineering Market?
The rise in chronic diseases and trauma-related emergencies are projected to fuel the expansion of the tissue engineering market. Chronic diseases, which refer to medical conditions enduring for more than three months that are typically manageable but not curable, together with trauma emergencies such as sudden-onset, severe injuries like traumatic brain injuries, are spurring this market growth. Healthcare professionals are increasingly using tissue engineering due to its benefits in treating chronic disorders and trauma, which helps preclude potential treatment failures including autologous or allograft transplantation, xenotransplantation, and the use of artificial substitutes. The World Health Organization's 2023 report reveals nearly 2.4 billion people globally suffer from chronic diseases, and there is a marked rise in diabetes and cardiovascular diseases. This escalating prevalence underscores the immediate requirement for innovative medical treatments, including tissue engineering solutions. Furthermore, the Centers for Disease Control and Prevention's 2023 statistics indicate traumatic brain injuries (TBIs) remain a huge concern in the US, with roughly 223,000 hospitalizations and 60,000 deaths annually, stressing the importance of efficacious interventions. As a consequence, the mounting incidence of chronic illness and trauma emergencies is predicted to generate considerable growth in the tissue engineering market.
What Are The Market Segments In The Tissue Engineering Market?
The tissue engineering market covered in this report is segmented –
1) By Type: Synthetic Scaffold Material, Biologically Derived Scaffold Material, Other Types
2) By Application: Orthopedics And Musculoskeletal, Neurology, Cardiovascular, Skin And Integumentary, Dental, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Facilities
Subsegments:
1) By Synthetic Scaffold Material: Polymeric Scaffolds, Ceramic Scaffolds, Composite Scaffolds
2) By Biologically Derived Scaffold Material: Natural Polymers, Decellularized Tissues, Hydrogels
3) By Other Types: Self-Healing Scaffolds, Smart Scaffolds
Pre-Book The Tissue Engineering Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Tissue Engineering Market?
Technological progression is a predominant trend attracting attention in the field of tissue engineering. Principal corporations in the market are directing their efforts towards research and development for innovative products that could bring improved solutions and fortify their market stance. For example, in August 2024, CytoNest Inc., an American firm involved in engineering scalable 3D cell culture platforms for manufacturing adhesive cells, launched its debut commercial product, a fiber scaffold that enhances cell production and tissue engineering. The product, named CytoSurge 3D fiber scaffold, is beneficial for cell research, biopharmaceuticals, cell treatments, and the manufacture of cultivated meat and seafood.
Who Are the Key Players In The Tissue Engineering Market?
Major companies operating in the tissue engineering market include:
• Medtronic plc
• Zimmer Biomet
• Organogenesis Holdings Inc.
• Integra LifeSciences
• Stryker Corporation
• DePuy Synthes Companies
• B. Braun Melsungen AG
• RTI Surgical Inc.
• AbbVie Inc.
• Becton Dickinson and Company
• Baxter International Inc.
• BioTime Inc.
• Vericel Corporation
• Smith and Nephew
• Athersys Inc.
• Tissue Regenix Group plc
• Xeltis AG
• Prellis Biologics
• Bit Bio
• Be Biopharma Inc.
• TELA Bio Inc.
• Orthocell Limited
What Are The Regional Insights Into The Tissue Engineering Market?
North America was the largest region in the tissue engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
